TriMas (TRS) Expected to Announce Earnings on Tuesday

TriMas (NASDAQ:TRS - Get Free Report) is anticipated to issue its Q1 2025 quarterly earnings data before the market opens on Tuesday, April 29th. Analysts expect the company to announce earnings of $0.43 per share and revenue of $235.41 million for the quarter.

TriMas Price Performance

Shares of TRS opened at $20.24 on Tuesday. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.44. The company has a market cap of $824.09 million, a P/E ratio of 31.63 and a beta of 0.55. TriMas has a 12 month low of $19.33 and a 12 month high of $28.51. The stock has a fifty day moving average price of $22.61 and a 200 day moving average price of $24.50.

TriMas Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Investors of record on Friday, February 28th were issued a $0.04 dividend. The ex-dividend date was Friday, February 28th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.79%. TriMas's dividend payout ratio (DPR) is presently 27.12%.

Insider Transactions at TriMas

In other news, Director Jeffrey A. Fielkow bought 2,500 shares of the business's stock in a transaction on Friday, February 28th. The stock was purchased at an average cost of $20.78 per share, for a total transaction of $51,950.00. Following the completion of the transaction, the director now directly owns 11,013 shares of the company's stock, valued at approximately $228,850.14. This trade represents a 29.37 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Shawn Sedaghat acquired 554,149 shares of the company's stock in a transaction dated Monday, March 10th. The stock was purchased at an average cost of $24.07 per share, for a total transaction of $13,338,366.43. Following the purchase, the director now directly owns 900,974 shares in the company, valued at approximately $21,686,444.18. This represents a 159.78 % increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders acquired 806,246 shares of company stock valued at $19,338,213. 14.20% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Separately, BWS Financial restated a "buy" rating and issued a $40.00 price target on shares of TriMas in a research note on Friday, February 28th.

About TriMas

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.